Wanbangde Pharmaceutical Holding Group Co., Ltd. (SHE:002082)
China · Delayed Price · Currency is CNY 11.59
+0.55 (4.98%)
Jul 3, 2026, 3:04 PM CST
SHE:002082 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | -79.49 | -167.24 | 55.44 | 49.21 | 93.26 | 166.51 |
Depreciation & Amortization | 104.17 | 104.17 | 104.12 | 96.94 | 107.03 | 94.98 |
Other Amortization | 12.09 | 12.09 | 2.94 | 1.71 | 1.2 | 1.24 |
Loss (Gain) From Sale of Assets | -0.6 | -0.6 | -15.74 | -0.12 | 0.95 | 1.21 |
Asset Writedown & Restructuring Costs | 6.13 | 6.13 | 21.75 | 2.88 | 90.27 | 47.37 |
Loss (Gain) From Sale of Investments | -10.75 | -10.75 | -20.23 | -0.66 | 0.06 | -229.65 |
Provision & Write-off of Bad Debts | 70.48 | 70.48 | -0.9 | 23.56 | 38.98 | 52.25 |
Other Operating Activities | 78.67 | 41.3 | 33.73 | 31.86 | 18.16 | 51.07 |
Change in Accounts Receivable | 486.88 | 486.88 | 12.88 | -15.2 | -101.79 | 178.83 |
Change in Inventory | -20.68 | -20.68 | 54.58 | 20.81 | -18.71 | 64.52 |
Change in Accounts Payable | 83.63 | 83.63 | -110.89 | -262.25 | -438.51 | -390.96 |
Operating Cash Flow | 729.1 | 603.98 | 120.22 | -72.87 | -239.65 | 22.09 |
Operating Cash Flow Growth | 46078.93% | 402.39% | - | - | - | -85.38% |
Capital Expenditures | -313.37 | -301.65 | -97.11 | -128.72 | -167.23 | -285.51 |
Sale of Property, Plant & Equipment | 0.44 | 0.75 | 49.45 | 0.2 | 4.3 | 0.27 |
Cash Acquisitions | - | - | -10.54 | - | - | - |
Divestitures | - | - | - | - | - | 1,293 |
Sale (Purchase) of Intangibles | - | - | - | - | -4.96 | -13.1 |
Investment in Securities | 6.92 | 7.72 | -79.26 | - | - | - |
Other Investing Activities | 11.34 | 10.51 | -23.12 | 8.45 | -1.15 | 5.07 |
Investing Cash Flow | -283.28 | -271.28 | -152.49 | -156.03 | -167.42 | 999.46 |
Short-Term Debt Issued | - | 2.67 | - | - | - | - |
Long-Term Debt Issued | - | 1,281 | 1,083 | 875.92 | 720.22 | 581.49 |
Total Debt Issued | 742.17 | 1,284 | 1,083 | 875.92 | 720.22 | 581.49 |
Long-Term Debt Repaid | - | -1,163 | -1,032 | -764.53 | -712.42 | -1,014 |
Total Debt Repaid | -573.7 | -1,163 | -1,032 | -764.53 | -712.42 | -1,014 |
Net Debt Issued (Repaid) | 168.47 | 120.59 | 50.72 | 111.39 | 7.8 | -432.13 |
Repurchase of Common Stock | - | - | - | - | -9.03 | -50.96 |
Common Dividends Paid | -47.88 | -47.7 | -90.84 | -122.03 | -43.91 | -191.66 |
Other Financing Activities | -48.23 | -15.76 | -2.21 | 19.89 | -17.93 | - |
Financing Cash Flow | 72.37 | 57.13 | -42.33 | 9.26 | -63.07 | -674.75 |
Foreign Exchange Rate Adjustments | -0.2 | 0.81 | -0.16 | -1.25 | 2.02 | -5.44 |
Net Cash Flow | 517.99 | 390.64 | -74.76 | -220.89 | -468.11 | 341.35 |
Free Cash Flow | 415.73 | 302.33 | 23.11 | -201.59 | -406.88 | -263.42 |
Free Cash Flow Growth | - | 1208.10% | - | - | - | - |
Free Cash Flow Margin | 35.34% | 27.06% | 1.60% | -13.07% | -22.78% | -13.64% |
Free Cash Flow Per Share | 0.67 | 0.49 | 0.04 | -0.33 | -0.65 | -0.43 |
Cash Income Tax Paid | 84.06 | 94.73 | 120.89 | 133.12 | 402.31 | 175.69 |
Levered Free Cash Flow | 473.71 | 353.89 | 56.41 | 44.08 | -373.4 | 800.46 |
Unlevered Free Cash Flow | 499.64 | 377.68 | 80.47 | 73.13 | -352.66 | 822.72 |
Change in Working Capital | 548.4 | 548.4 | -60.88 | -278.24 | -589.57 | -162.88 |